Virtual Reality-based Training in Cerebellar Ataxia

September 8, 2016 updated by: Yea-Ru Yang, National Yang Ming University
The purpose of this study was to investigate the effects of virtual reality-base training for cerebellar ataxia.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • diagnosis of SCA 1, 2, 3 and 6 by a neurologist
  • ability to walk independently with or without any walking aids
  • age ≥ 20
  • a score of ≥ 24 on the mini-mental state examination

Exclusion Criteria:

  • histories of other neurological, cardiovascular, or orthopedic diseases affecting motor performance and balance
  • uncontrolled chronic diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exergaming training
Participants in the exergaming training group received a 4-week exergaming intervention.
Other: Exergaming training
Active Comparator: Control training
Participants in the control training group received a 4-week conventional training.
Other: Physical therapy intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Scale for the Assessment and Rating of Ataxia
Time Frame: Change from baseline at 4 weeks
Change from baseline at 4 weeks
Alternate nose to finger test
Time Frame: Change from baseline at 4 weeks
Change from baseline at 4 weeks
Alternate heel on shin test
Time Frame: Change from baseline at 4 weeks
Change from baseline at 4 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Nine-hole peg test
Time Frame: Change from baseline at 4 weeks
Change from baseline at 4 weeks
Walking speed
Time Frame: Change from baseline at 4 weeks
Change from baseline at 4 weeks
Step width
Time Frame: Change from baseline at 4 weeks
Change from baseline at 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Yang Ming University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2014

Primary Completion (Actual)

July 1, 2015

Study Completion (Actual)

September 1, 2015

Study Registration Dates

First Submitted

September 6, 2016

First Submitted That Met QC Criteria

September 8, 2016

First Posted (Estimate)

September 14, 2016

Study Record Updates

Last Update Posted (Estimate)

September 14, 2016

Last Update Submitted That Met QC Criteria

September 8, 2016

Last Verified

September 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 201410010A

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebellar Ataxia

Clinical Trials on Exergaming training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe